Abstract
The use of atazanavir (ATV) in adolescents infected with human immunodeficiency virus was analyzed in this study. ATV morning plasma concentrations were determined during regular visits to the outpatient department. Results showed that bilirubin levels were higher among patients with higher ATV plasma concentrations (p = .018). Monitoring plasma levels of ATV could avoid toxicity in these patients.
Copyright © 2011 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adolescent Health Services
-
Anti-HIV Agents / administration & dosage
-
Atazanavir Sulfate
-
Bilirubin / blood*
-
Child
-
Drug Administration Schedule
-
Drug Monitoring
-
Female
-
HIV Infections / blood*
-
HIV Infections / drug therapy*
-
Humans
-
Hyperbilirubinemia / prevention & control
-
Male
-
Oligopeptides / administration & dosage*
-
Oligopeptides / blood*
-
Pyridines / administration & dosage*
-
Pyridines / blood*
-
Spain
Substances
-
Anti-HIV Agents
-
Oligopeptides
-
Pyridines
-
Atazanavir Sulfate
-
Bilirubin